BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 22, 2008
View Archived Issues
GlaxoSmithKline full year 2007
Read More
New agents for treating endocrine-related disorders disclosed in recent patent literature
Read More
Novel treatment options for HIV infection reported by Mintaka
Read More
No viral resistance to R-7128 seen in HCV genotype 1 patients
Read More
Antiangiogenic gene therapy potentially useful for metastatic renal cell carcinoma
Read More
Perlegen and SC Liver Research Consortium to collaborate on interferon response in HCV
Read More
NeuroHealing initiates phase II clinical trial of NH-004 for sialorrhea in PD patients
Read More
ActivBiotics to conduct clinical trial to compare rifalazil and azithromycin in Chlamydia
Read More
Recordati is granted Australian approval for Zan-Extra for hypertension
Read More
Association between GVAX-induced immune responses and survival in patients with prostate cancer
Read More
New compounds for treating pain and other inflammatory conditions described in recent patents
Read More
Proteomic analysis identifies new potential targets for multiple sclerosis
Read More
Novel human monoclonal antibody against Hendra and Nipah viruses discovered
Read More
Addrenex files NDA for CloniBID for the treatment of hypertension
Read More
ConjuChem initiates phase II PC-DAC:Exendin-4 study
Read More
Glenmark's GRC-4039 enters phase I trials in rheumatoid arthritis
Read More
Millennium expands Velcade for injection program in non-Hodgkin's lymphoma
Read More
VaxGen encourages stockholders to vote in favor of the merger
Read More
Sciele Pharma launches LifeCycle Pharma's cholesterol-lowering Fenoglide in the U.S.
Read More
FDA Advisory Committee recommends Rotarix oral rotavirus vaccine for infants
Read More
Lilly receives positive opinion from the EMEA for Forsteo in GIO
Read More
FDA approves Wyeth's Xyntha for hemophilia A therapy
Read More
Antisoma commences phase I clinical study of AS-1409 in renal cancer and melanoma
Read More
